Multiplex Vaginal Panel (MVP) delivers faster identification of three distinct conditions within an hour SUNNYVALE, Calif., Jan. 18, 2024 /PRNewswire/ -- Cepheid announced today that it has received ...

SUNNYVALE, Calif., Jan. 18, 2024 /PRNewswire/ -- Cepheid announced today that it has received FDA Clearance with Clinical Laboratory Improvement Amendments (CLIA) waiver for Xpert® Xpress MVP. This ...

Cepheid 's CPHD rapid influenza and RSV assay - the Xpert Flu+RSV Xpress test - recently won the U.S. FDA 510(k) marketing approval and the Clinical Laboratory Improvement Achievements (CLIA) waiver.

1.该研究比较了BIOFIRE SPOTFIRE、Xpert Xpress和Cobas Liat三种多通路呼吸道检测平台对流感A/B、SARS-CoV-2和RSV的检测性能，发现SPOTFIRE在 ...

SUNNYVALE, Calif., June 9, 2020 /PRNewswire/ -- Cepheid today announced the development of a next-generation test to assist global efforts in the fight against the spread of COVID-19 during the ...

Cepheid announced that it has received US FDA clearance with Clinical Laboratory Improvement Amendments (CLIA) waiver for Xpert Xpress MVP. This multiplex vaginal panel can now be performed in ...

本研究首次在CLIA认证（CA）和豁免（CW）场景下，评估了Cepheid Xpert Xpress CoV-2/Flu/RSV plus对鼻咽拭子（NPS）和前鼻拭子（NS）样本 ...

SUNNYVALE, Calif., May 2, 2018 /PRNewswire/ -- Cepheid announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and waiver under the Clinical Laboratory ...